Erectile dysfunction after PlasmaKinetic vaporization of the prostate: Incidence and risk factors

Journal of Endourology

Volumn 20, Issue 9, 2006, Pages 693-697

  Pu, Xiaoyong ^a,b   Wang, Xinghuan ^b   Wang, Huaipeng ^b   Hu, Liquan ^a  

^a WUHAN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PENIS NOCTURNAL TUMESCENCE; PLASMAKINETIC VAPORIZATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; VAPORIZATION;

AGED; AGED, 80 AND OVER; CATHETER ABLATION; DIABETES COMPLICATIONS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; RISK FACTORS; VOLATILIZATION;

EID: 33846449471     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.20.693     Document Type: Article

References (37)

1. Jepsen JV Bruskewitz RC. Recent developments in the surgical management of benign prostatic hyperplasia. Urology 1998;51(suppl 4A):23.
2. Soderdahl DW, Knight RW, Hansberry KL. Erectile dysfunction following transurethral resection of the prostate. J Urol 1996;156:1354.
3. Holtgrewe HL, Valk WL. Late results of transurethral prostatectomy. J Urol 1964;92:51.
4. Hargreave TB, Stephenson TP. Potency and prostatactomy. Br J Urol 1977;49:683.
5. Samdal F, Vada K, Lundmo P. Sexual function after transurethral prostatectomy. Scand J Urol Nephrol 1993;27:27.
6. Finkle AL, Prian DV. Sexual potency in elderly men before and after prostatectomy. JAMA 1969;196:139.
7. Bieri S, Iselin CE, Rohner S. Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997;31:545.
8. Perera ND, Hill JT. Erectile and ejaculatory failure after transurethral prostatectomy. Ceylon Med J 1998;43:74.
9. Vale J. Benign prostatic hyperplasia and erectile dysfunction-Is there a link? Curr Med Res Opin 2000;16(Suppl 1):s63.
10. Brookes ST. Donovan JL. Peters TJ, et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms: Evidence from randomised controlled trial. BMJ 2002;324:1059.
11. Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet 2003;361:60.
12. Taher A. Erectile dysfunction after transurethral resection of the prostate: Incidence and risk factors. World J Urol 2004;22:457.
13. Simpson RJ. Benign prostatic hyperplasia. Br J Gen Pract 1997;47:235.
14. Dincel C, Samli MM, Guler C, et al. PlasmaKinetic vaporization of the prostate: Clinical evaluation of a new technique. J Endourol 2004;18:293.
15. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (HEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822.
16. Zimmern P, Leach GE, Yao J, et al. Criteria of RigiScan normalcy in aged men. Prog Urol 1999;9:37.
17. Broderick GA. Evidence based assessment of erectile dysfunction. Int J Impot Res 1998;10(suppl 2):s64.
18. Rosen RC. Sexual function assessment in the male: Physiological and self-report measures. Int J Impot Res 1998;10(suppl 2):s59.
19. Karadeniz T, Topsakal M, Aydogmus A, et al. Role of RigiScan in the etiologic differential diagnosis of erectile dysfunction. Urol Int 1997;59:41.
20. Guay AT, Heatley GJ, Murray FT. Comparison of results of nocturnal penile tumescence and rigidity in a sleep laboratory versus a portable home monitor. Urology 1996;48:912.
21. Bradley WE. New techniques in evaluation of impotence. Urology 1987;29:383.
22. Morales A, Condra M, Reid K. The role of nocturnal penile tumescence monitoring in the diagnosis of impotence: A review. J Urol 1990;143:441.
23. Nuhoglu B, Ayyildiz A, Fidan V, et al. Transurethral electrovaporization of the prostate: Is it any better than standard transurethral prostatectomy? 5-year follow-up. J Endourol 2005;19:79.
24. Hammadeh MY, Madaan S, Singh M, et al. A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy. BJU Int 2000;86:648.
25. Patel A, Fuchs GJ, Gutierrez-Aceves J, et al. Transurethral electrovaporization and vapour-resection of the prostate: An appraisal of possible electrosurgical alternatives to regular loop resection. BJU Int 2000;85:202.
26. Browning AJ. PlasmaKinetic vaporization of the prostate. J Urol 1999;161(suppl):391.
27. Smith D, Khoubehi B, Patel A. Bipolar electrosurgery for benign prostatic hyperplasia: Transurethral electrovaporization and resection of the prostate. Curr Opin Urol 2005;15:95.
28. Holtgrewe HL, Mebust WK, Dowd JB, et al. Transurethral prostatectomy: Practice aspects of the dominant operation in American urology. J Urol 1989;141:248.
29. Hanbury DC, Sethia KK. Erectile function following transurethral prostatectomy. Br J Urol 1995;75:12.
30. Bolt JW, Evans C, Marshall VR. Sexual dysfunction after prostatectomy. Br J Urol 1987;59:319.
31. Mebust WK, Holtgrewe HL, Cockett AT, et al. Transurethral prostatectomy: Immediate and postoperative complications: A co-operative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243.
32. Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75.
33. Kinn AC, Helmy-Dhejne C, Larsson J. Sexual function one year after transurethral prostatic resection: Patients' own assessments. Scand J Urol Nephrol 1998;32:33.
34. Tscholl R, Largo M, Poppinghaus E, et al. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995;153:1491.
35. Parsons CI. Impotence following transurethral resection of the prostate. In: Common Problems in Infertility and Impotence. Chicago: Year Book Medical Publishers, 1990, p 352.
36. Tsai YS, Lin JS, Tong YC, et al. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: Longterm durability with Prostcare. Eur Urol 2001;39:688.
37. Roehrborn CG., Issa MM, Bruskewitz RC, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998;51:415.